Literature DB >> 23879376

KHA-CARI Guideline: use of iron in chronic kidney disease patients.

Rob Macginley1, Rowan Walker, Michelle Irving.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23879376     DOI： 10.1111/nep.12139

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN： 1320-5358            Impact factor:   2.506


× No keyword cloud information.
  7 in total

1.  Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial.

Authors:  Matthew A Roberts; Louis Huang; Darren Lee; Robert MacGinley; Stefanie M A Troster; Annette B Kent; Sukhvinder S Bansal; Iain C Macdougall; Lawrence P McMahon
Journal:  BMC Nephrol       Date:  2016-11-16       Impact factor: 2.388

2.  Assessing the Association between Serum Ferritin, Transferrin Saturation, and C-Reactive Protein in Northern Territory Indigenous Australian Patients with High Serum Ferritin on Maintenance Haemodialysis.

Authors:  Sandawana William Majoni; Paul D Lawton; Federica Barzi; Alan Cass; Jaquelyne T Hughes
Journal:  Int J Nephrol       Date:  2017-01-24

Review 3.  Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease.

Authors:  Simon D Roger
Journal:  Clin Kidney J       Date:  2017-11-28

Review 4.  Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.

Authors:  Maria Domenica Cappellini; Josep Comin-Colet; Angel de Francisco; Axel Dignass; Wolfram Doehner; Carolyn S Lam; Iain C Macdougall; Gerhard Rogler; Clara Camaschella; Rezan Kadir; Nicholas J Kassebaum; Donat R Spahn; Ali T Taher; Khaled M Musallam
Journal:  Am J Hematol       Date:  2017-07-07       Impact factor: 10.047

Review 5.  Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.

Authors:  Norishi Ueda; Kazuya Takasawa
Journal:  Nutrients       Date:  2018-08-27       Impact factor: 5.717

6.  INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trial.

Authors:  Sandawana William Majoni; Jane Nelson; Darren Germaine; Libby Hoppo; Stephanie Long; Shilpa Divakaran; Brandon Turner; Jessica Graham; Sajiv Cherian; Basant Pawar; Geetha Rathnayake; Bianca Heron; Louise Maple-Brown; Robert Batey; Peter Morris; Jane Davies; David Kiran Fernandes; Madhivanan Sundaram; Asanga Abeyaratne; Yun Hui Sheryl Wong; Paul D Lawton; Sean Taylor; Federica Barzi; Alan Cass
Journal:  Trials       Date:  2021-12-02       Impact factor: 2.279

Review 7.  Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis.

Authors:  Simon D Roger; Martin Tio; Hyeong-Cheon Park; Hui Lin Choong; Bakleong Goh; Timothy Robert Cushway; Vanessa Stevens; Iain C Macdougall
Journal:  Nephrology (Carlton)       Date:  2017-12       Impact factor: 2.506
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.